Your browser doesn't support javascript.
loading
An α-glucosidase inhibitor could reduce T-wave alternans in type 2 diabetes patients.
Eguchi, Kazuo; Komori, Takahiro; Saito, Toshinobu; Hoshide, Satoshi; Kario, Kazuomi.
Affiliation
  • Eguchi K; Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University, Tochigi, Japan. Electronic address: ke112@jichi.ac.jp.
  • Komori T; Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University, Tochigi, Japan.
  • Saito T; Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University, Tochigi, Japan.
  • Hoshide S; Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University, Tochigi, Japan.
  • Kario K; Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University, Tochigi, Japan.
J Electrocardiol ; 51(1): 21-26, 2018.
Article in En | MEDLINE | ID: mdl-28918212
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arrhythmias, Cardiac / Electrocardiography, Ambulatory / 1-Deoxynojirimycin / Diabetes Mellitus, Type 2 / Glycoside Hydrolase Inhibitors Type of study: Clinical_trials Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: J Electrocardiol Year: 2018 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arrhythmias, Cardiac / Electrocardiography, Ambulatory / 1-Deoxynojirimycin / Diabetes Mellitus, Type 2 / Glycoside Hydrolase Inhibitors Type of study: Clinical_trials Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: J Electrocardiol Year: 2018 Document type: Article Country of publication: United States